Suppr超能文献

一种伴有慢性血小板减少、贫血和早发性中风的新型腺苷脱氨酶2缺乏症变体。

A Novel Variant of Adenosine Deaminase 2 Deficiency Presented With Chronic Thrombocytopenia, Anemia, and Early-Onset Stroke.

作者信息

Al-Hebshi Abdulqader, Aljohani Maher, AlShenaifi Naif, Aloqbi Maryam, Turkistani Waheed, Hakami Fahad

机构信息

Pediatric Hematology Oncology, Ministry of National Guard Health Affairs, Medina, SAU.

Pediatrics, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, SAU.

出版信息

Cureus. 2021 May 28;13(5):e15288. doi: 10.7759/cureus.15288.

Abstract

Deficiency of adenosine deaminase 2 (DADA2) is a rare recessive disorder caused by the bi-allelic loss-of-function pathogenic variants in the gene (MIM: 607575, also known as , cat eye syndrome chromosome region, candidate 1). Based on the Human Gene Mutation Database (HGMD), 53 different disease-causing variants have been identified in this gene to date. This case report aims to describe a new vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome (VAIHS) case caused by a novel pathogenic variant. A four-year-old boy was referred to our hospital with anemia, thrombocytopenia, and stroke, but no skin manifestations. The patient had a significant phenotypic overlap with VAIHS. Molecular genetic analysis via whole exome sequencing identified a homozygous deleterious variant in . To our knowledge, the identified variant has never been described in the literature. Screening for pathogenic variants should be considered in the differential diagnosis of pediatric patients manifesting with chronic thrombocytopenia or early-onset stroke for an accurate diagnosis and appropriate treatment choices.

摘要

腺苷脱氨酶2(DADA2)缺乏症是一种罕见的隐性疾病,由该基因(MIM:607575,也称为猫眼综合征染色体区域候选基因1)的双等位基因功能丧失性致病变异引起。基于人类基因突变数据库(HGMD),迄今为止已在该基因中鉴定出53种不同的致病变体。本病例报告旨在描述一例由新型致病变异引起的新的血管炎、自身炎症、免疫缺陷和血液学缺陷综合征(VAIHS)病例。一名4岁男孩因贫血、血小板减少和中风被转诊至我院,但无皮肤表现。该患者与VAIHS有明显的表型重叠。通过全外显子测序进行的分子遗传学分析在该基因中鉴定出一个纯合有害变体。据我们所知,已鉴定出的变体在文献中从未被描述过。对于表现为慢性血小板减少或早发性中风的儿科患者,在鉴别诊断中应考虑筛查该基因的致病变异,以进行准确诊断和做出适当的治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/428e/8237765/16e49ab27550/cureus-0013-00000015288-i01.jpg

相似文献

2
Deficiency of Adenosine Deaminase 2 (DADA2): Hidden Variants, Reduced Penetrance, and Unusual Inheritance.
J Clin Immunol. 2020 Aug;40(6):917-926. doi: 10.1007/s10875-020-00817-3. Epub 2020 Jul 8.
3
Adenosine Deaminase Two and Immunoglobulin M Accurately Differentiate Adult Sneddon's Syndrome of Unknown Cause.
Cerebrovasc Dis. 2018;46(5-6):257-264. doi: 10.1159/000495794. Epub 2019 Jan 15.
5
A novel frameshift variant in the ADA2 gene of a patient with a neurological phenotype: a case report.
Pediatr Rheumatol Online J. 2022 Dec 17;20(1):118. doi: 10.1186/s12969-022-00781-9.
6
Atypical presentation of adenosine deaminase 2 deficiency with bi-allelic ADA2 mutation.
Clin Case Rep. 2022 Mar 1;10(3):e05408. doi: 10.1002/ccr3.5408. eCollection 2022 Mar.
8
Early-onset stroke and vasculopathy associated with mutations in ADA2.
N Engl J Med. 2014 Mar 6;370(10):911-20. doi: 10.1056/NEJMoa1307361. Epub 2014 Feb 19.
9
Identification of Novel Adenosine Deaminase 2 Gene Variants and Varied Clinical Phenotype in Pediatric Vasculitis.
Arthritis Rheumatol. 2019 Oct;71(10):1747-1755. doi: 10.1002/art.40913. Epub 2019 Aug 26.
10
Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment.
J Clin Immunol. 2018 Jul;38(5):569-578. doi: 10.1007/s10875-018-0525-8. Epub 2018 Jun 27.

引用本文的文献

1
Mimics and challenging presentations of DADA2.
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxaf017.
2
Deficiency of adenosine deaminase 2 (DADA2) with recurrent ischemic stroke, fever and cutaneous changes: A case report.
Neurol Sci. 2025 Jun;46(6):2867-2874. doi: 10.1007/s10072-025-07991-5. Epub 2025 Jan 11.
3
Deficiency of Human Adenosine Deaminase Type 2 - A Diagnostic Conundrum for the Hematologist.
Front Immunol. 2022 May 3;13:869570. doi: 10.3389/fimmu.2022.869570. eCollection 2022.

本文引用的文献

1
Human adenosine deaminase 2 deficiency: A multi-faceted inborn error of immunity.
Immunol Rev. 2019 Jan;287(1):62-72. doi: 10.1111/imr.12722.
2
Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency.
J Allergy Clin Immunol. 2019 Mar;143(3):852-863. doi: 10.1016/j.jaci.2018.08.024. Epub 2018 Sep 5.
3
Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment.
J Clin Immunol. 2018 Jul;38(5):569-578. doi: 10.1007/s10875-018-0525-8. Epub 2018 Jun 27.
4
5
Clinical, imaging and genotypical features of three deceased and five surviving cases with ADA2 deficiency.
Rheumatol Int. 2018 Jan;38(1):129-136. doi: 10.1007/s00296-017-3740-3. Epub 2017 May 17.
6
Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations.
Rheumatology (Oxford). 2016 May;55(5):902-10. doi: 10.1093/rheumatology/kev439. Epub 2016 Feb 10.
7
Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy.
N Engl J Med. 2014 Mar 6;370(10):921-31. doi: 10.1056/NEJMoa1307362. Epub 2014 Feb 19.
8
Early-onset stroke and vasculopathy associated with mutations in ADA2.
N Engl J Med. 2014 Mar 6;370(10):911-20. doi: 10.1056/NEJMoa1307361. Epub 2014 Feb 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验